Follow
Christopher Hunter
Christopher Hunter
Verified email at vet.upenn.edu
Title
Cited by
Cited by
Year
IL-6 as a keystone cytokine in health and disease
CA Hunter, SA Jones
Nature immunology 16 (5), 448-457, 2015
20822015
Guidelines for the use of flow cytometry and cell sorting in immunological studies
A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ...
European journal of immunology 49 (10), 1457-1973, 2019
12572019
Interleukin 27 negatively regulates the development of interleukin 17–producing T helper cells during chronic inflammation of the central nervous system
JS Stumhofer, A Laurence, EH Wilson, E Huang, CM Tato, LM Johnson, ...
Nature immunology 7 (9), 937-945, 2006
11302006
Control of effector CD8+ T cell function by the transcription factor Eomesodermin
EL Pearce, AC Mullen, GA Martins, CM Krawczyk, AS Hutchins, ...
Science 302 (5647), 1041-1043, 2003
11252003
New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions
CA Hunter
Nature Reviews Immunology 5 (7), 521-531, 2005
10242005
Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10
JS Stumhofer, JS Silver, A Laurence, PM Porrett, TH Harris, LA Turka, ...
Nature immunology 8 (12), 1363-1371, 2007
9372007
Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation
RA Kastelein, CA Hunter, DJ Cua
Annu. Rev. Immunol. 25, 221-242, 2007
9092007
Anti–IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis
Y Chen, CL Langrish, B Mckenzie, B Joyce-Shaikh, JS Stumhofer, ...
The Journal of clinical investigation 116 (5), 1317-1326, 2006
7512006
NF-κB family of transcription factors: central regulators of innate and adaptive immune functions
J Caamano, CA Hunter
Clinical microbiology reviews 15 (3), 414-429, 2002
7202002
Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection
G Oldenhove, N Bouladoux, EA Wohlfert, JA Hall, D Chou, S O'Brien, ...
Immunity 31 (5), 772-786, 2009
6152009
The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection
A Villarino, L Hibbert, L Lieberman, E Wilson, T Mak, H Yoshida, ...
Immunity 19 (5), 645-655, 2003
5742003
Modulation of innate immunity by Toxoplasma gondii virulence effectors
CA Hunter, LD Sibley
Nature Reviews Microbiology 10 (11), 766-778, 2012
5532012
Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4-or IL-13-mediated signaling
JM Brewer, M Conacher, CA Hunter, M Mohrs, F Brombacher, ...
The Journal of Immunology 163 (12), 6448-6454, 1999
5281999
Trafficking of immune cells in the central nervous system
EH Wilson, W Weninger, CA Hunter
The Journal of clinical investigation 120 (5), 1368-1379, 2010
5242010
Cytokine storms: understanding COVID-19
N Mangalmurti, CA Hunter
Immunity 53 (1), 19-25, 2020
5082020
Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis.
CM Coughlin, KE Salhany, M Wysocka, E Aruga, H Kurzawa, AE Chang, ...
The Journal of clinical investigation 101 (6), 1441-1452, 1998
4991998
Generalized LÚvy walks and the role of chemokines in migration of effector CD8+ T cells
TH Harris, EJ Banigan, DA Christian, C Konradt, ED Tait Wojno, K Norose, ...
Nature 486 (7404), 545-548, 2012
4932012
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies
M Ruella, DM Barrett, SS Kenderian, O Shestova, TJ Hofmann, ...
The Journal of clinical investigation 126 (10), 3814-3826, 2016
4822016
The composition and signaling of the IL-35 receptor are unconventional
LW Collison, GM Delgoffe, CS Guy, KM Vignali, V Chaturvedi, ...
Nature immunology 13 (3), 290-299, 2012
4682012
Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin
AM Intlekofer, A Banerjee, N Takemoto, SM Gordon, CS DeJong, H Shin, ...
Science 321 (5887), 408-411, 2008
4552008
The system can't perform the operation now. Try again later.
Articles 1–20